Tech Company Financing Transactions
Transgenomic Funding Round
Transgenomic, based in Omaha, received $8 million from Third Security.
Transaction Overview
Company Name
Announced On
3/16/2013
Transaction Type
Debt
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the facility will be used to refinance the Company's outstanding debt with Forest Laboratories and to help fund working capital requirements.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
12325 Emmet St.
Omaha, NE 68164
USA
Omaha, NE 68164
USA
Phone
Website
Email Address
Overview
Transgenomic, Inc. (OTCBB: TBIO) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Kinnon
Chief Financial Officer
Leon Richards
Vice President
Steve Miller
VP - Human Resources
Joanne Lewis
Browse more venture capital transactions:
Prev: 3/16/2013: iPawn venture capital transaction
Next: 3/16/2013: Arkadium venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs